About National Alzheimer's Disease Awareness

Sign up and be counted as a Champion!

Sign up and be counted as a Champion!

First name:
.
Last name:
.
E-mail:
.
ZIP:
.
Check to receive email

Labels

Alzheimer's disease (15) Health (10) Conditions and Diseases (9) United States (8) ALZHEIMER'S (7) Dementia (6) Jasmine Elisa (6) Alzheimer's Association (5) Neurological Disorders (5) alzheimers (4) Awareness (3) Long term care insurance (3) Maria Shriver (3) NORM MAC (3) White House (3) Disease (2) Green tea (2) New York Times (2) South Korea (2) Tea (2) Traditional Chinese medicine (2) United States Disease Alzheimer's disease Chicago Health Alzheimers disease older americans Dementia Conditions and Diseases (2) Winnipeg (2) Winnipeg Free Press (2) ...In Translation (1) Adalimumab (1) Alprazolam (1) Alzheimer (1) Alzheimers disease (1) American Academy of Neurology (1) Austin Hospital Melbourne (1) Barack Obama (1) Beta amyloid (1) Body mass index (1) Cancer (1) Cognition (1) Dallas (1) Digestion (1) Doctor of Philosophy (1) Etanercept (1) Facebook (1) Facebook features (1) Florida (1) Food (1) Infliximab (1) Insurance (1) Jae Hee (1) Jerry Brown (1) Karolinska Institutet (1) Kim Hye-jin (1) Los Angeles (1) Melbourne (1) Mental Health Research Institute (1) Mexico (1) Microsoft PowerPoint (1) Mouse (1) New America Media (1) Newcastle University (1) Non-steroidal anti-inflammatory drug (1) Nursing home (1) Obesity (1) Pete Rouse (1) Physical examination (1) Positron emission tomography (1) Rheumatoid arthritis (1) Sandra Day O'Connor (1) Selective serotonin reuptake inhibitor (1) Seoul (1) Silicon Valley (1) Stockholm (1) Support group (1) THE NEW YORK TIMES COMPANY (1) TNF inhibitor (1) Twitter (1) University of Texas Southwestern Medical Center (1) Xanax (1) is (1) jasmine beltran Los Angeles (1)

Tuesday, May 24, 2011

A Heart-Healthy Diet That’s Good for the Brain...


May 24, 2011 Nutrition scientists continue to extol the virtues of a Mediterranean diet, the traditional diet from Italy, Greece and other countries that border the Mediterranean Sea. The diet, high in fruits and vegetables and healthy fats like olive oil, along with modest amounts of red wine and little red meat, may curb heart disease and prolong life – and keep your mind sharp and free of Alzheimer’s disease in old age, studies suggest.
Now a large new study from Rush Medical College in Chicago provides the strongest evidence to date that a Mediterranean style diet may be good for the brain. Researchers studied 3,790 men and women ages 65 and older, tracking them over many years beginning in 1993. They were given regular questionnaires about the foods they ate, along with tests of memory and thinking skills every three years.
Those seniors who adhered to a Mediterranean diet most strictly scored higher on mental acuity and memory tests than those who didn’t eat much of the heart-healthy foods. Overall, those who stuck most closely to a Mediterranean diet were two years younger in “brain age” than their peers who didn’t follow such a diet. The findings held even after adjusting for risk factors like age, sex, race, years of education and participation in mentally stimulating activities.
The researchers caution that they could not account for all the many factors that may contribute to cognitive decline in old age. Food surveys, in which people fill out what they eat, can be unreliable, though the researchers used scientifically validated methods to analyze the results, and the study involved a large number of people.
The findings, which appeared in the American Journal of Clinical Nutrition, bolster a growing body of evidence that a heart-healthy Mediterranean diet is good for the brain. Earlier, smaller studies have reported that healthy people who follow a Mediterranean diet lower their risk of developing Alzheimer’s disease. And those with Alzheimer’s who followed such a diet lived longer than their peers who did not. Earlier research has also shown that a Mediterranean diet may cut the risk of strokes, cancer, diabetes and possibly other illnesses as well.
Doctors are not sure why a Mediterranean diet may be good for the brain. One possibility is that such a diet reduces a risk for blood vessel disease, which may contribute to the risk for Alzheimer’s disease. A Mediterranean diet helps cut down on inflammatory substances in the body, too, and inflammation has increasingly been tied to heart disease and possibly Alzheimer’s as well. Fruits, vegetables and red wine are also high in cell-protecting antioxidants.
Key components of the Mediterranean diet include:
  • An abundance of fiber-rich fruits, vegetables, cereals, nuts and beans;
  • Choosing “good” fats like olive or canola oil, rather than butter or lard, and limiting dairy products like high-fat cheese and milk;
  • Eating moderate amounts of fish and poultry, rather than red meat; and
  • Drinking a glass or two of red wine a day.
Many other factors besides diet, including the genes you inherit and advancing age, play an important role in who ultimately develops Alzheimer’s. Still, the findings suggest that lifestyle factors can have an impact on Alzheimer’s risk. Eating a heart-healthy diet, along with getting regular exercise and keeping weight down, may help keep the brain young.
By ALZinfo.org, The Alzheimer’s Information Site. Reviewed by William J. Netzer, Ph.D., Fisher Center for Alzheimer’s Research Foundation at The Rockefeller University.
Source: Tangney CC, Kwasny MJ, Li H, Wilson RS, Evans DA, Morris MC: “Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population.” American Journal of Clinical Nutrition, Dec. 22, 2010.
May 24, 2011
Having a thick middle, high blood pressure and other risk factors for heart disease may increase your risk of Alzheimer’s disease and other forms of dementia as well, a new study reports.
The findings come from France, where researchers studied more than 7,000 men and women ages 65 and older living in three French cities. Those who had a constellation of symptoms called “metabolic syndrome” – including hypertension, a large waistline, high levels of a type of blood fat called triglycerides, low levels of “good” HDL cholesterol, and poor control of blood sugar, a sign of impending diabetes – tended to perform worse on memory and thinking skills tests than those without these issues. Performing poorly on such tests is often an indicator of an increased risk of Alzheimer’s and other forms of dementia. The findings appeared in Neurology, the medical journal of the American Academy of Neurology.
Metabolic syndrome has long been linked to an increased risk of heart attacks. It is not an actual disease but rather a group of symptoms. The findings support a growing body of evidence that factors like a large waistline and high blood pressure – whether in midlife or beyond — may be linked to diminishing thinking skills and possibly even Alzheimer’s disease.
“Our study sheds new light on how metabolic syndrome and the individual factors of the disease may affect cognitive health,” said study author Christelle Raffaitin, M.D., of the French National Institute of Health Research in Bordeaux. “Our results suggest that management of metabolic syndrome may help slow down age-related memory loss, or delay the onset of dementia.”
At the start of the study, researchers evaluated the 4,323 women and 2,764 men and found that 16 percent had metabolic syndrome. All the participants were given memory tests two and four years later.

Those with metabolic syndrome were 20 percent more likely to have a decline in thinking and memory skills than those without the syndrome. Two factors in particular were linked to declining memory: higher triglycerides and low HDL, or “good” cholesterol. Having diabetes was also linked to memory problems, although high blood sugar levels were not.

The authors propose that taking steps to reduce metabolic syndrome may help to ward off or slow down mental decline in old age. Increasingly, Alzheimer’s is seen as a disease that may take years or even decades to develop. Taking measures to slow cognitive decline could, potentially help to keep thinking sharp and postpone the onset of full-blown Alzheimer’s by many years.

By ALZinfo.org, The Alzheimer’s Information Site. Reviewed by William J. Netzer, Ph.D., Fisher Center for Alzheimer’s Research Foundation at The Rockefeller University.
Source: C. Raffaitin, MD, C. Feart, PhD, M. Le Goff, MSc, et al: “Metabolic Syndrome and Cognitive Decline in French Elders: The Three-City Study.” Neurology, Feb 2, 2011, Vol. 76, pages 518-525.

Brain Scans Lead to Earlier Alzheimer’s Diagnosis | Fisher Center for Alzheimer's Research Foundation

May 24, 2011
Scientists are moving closer to diagnosing Alzheimer’s disease at an earlier stage using special brain scans. The scans, which are not routinely available in doctors’ offices, should make it easier to know for sure whether someone has Alzheimer’s earlier in its course, when treatments may be more effective and patients can better plan for the future. Currently, the only way to get a definitive diagnosis is to examine the brain after death during an autopsy.
The imaging technique picks up the presence in the brain of plaques, which are made up of clumps of beta-amyloid protein fragments. Plaques are a telltale sign that someone has Alzheimer’s, though their role in the disease is not well understood. Someone may have dementia, but if they do not have plaques, their dementia is due to a condition other than Alzheimer’s.
Between 10 and 20 percent of people who are given a diagnosis of Alzheimer’s turn out not to have the disease when their brains are examined at autopsy. And doctors miss the diagnosis of Alzheimer’s in about a third of patients with early disease and only mild memory loss and other symptoms. Someone who comes to the doctor’s office complaining of depression, for example, may actually be in the early stages of Alzheimer’s.
The imaging techniques involve the use of positron emission tomographic, or PET, scans. They use various dyes that latch on to particles of beta-amyloid in the brain, making it possible to see plaques on the brain scans in living people.
Most recently, an advisory panel to the US Food and Drug Administration recommended approval of an imaging technique developed by Avid Radiopharmaceuticals, pending further study of the technique. The company has developed a brain dye called florbetapir F 18 that attaches to beta-amyloid, which then lights up on PET scans.
In a recent study, florbetapir-PET imaging was performed on the brains of 35 men and women who were in hospice or long-term care facilities and nearing the end of their lives, about half of whom were thought to have Alzheimer’s. Their brains were then examined after they died, to see if the PET scans in the living people were consistent with the findings on autopsy.
In almost all the cases, the living brain scans matched the autopsy findings. One patient who was thought to have Alzheimer’s actually had dementia of other causes. Two others turned out to have Alzheimer’s, though they were given other diagnoses while alive.
Similar scans were performed on 74 young and healthy individuals under age 50. Presumably, their brains would be relatively free of plaque, which turned out to be the case. The study appeared in the Journal of the American Medical Association.
The findings give new weight that such scanning techniques will prove effective in diagnosing Alzheimer’s definitively at earlier stages. Scientists need to do further study to determine how much plaque defines a diagnosis, and doctors need to be trained in carrying out and interpreting test results.
The technique is also being used to assess the effects of various Alzheimer’s drugs in development. By monitoring brain plaques, researchers can determine whether an experimental drug is working by preventing the buildup of beta-amyloid in the brain. Current medications for Alzheimer’s may ease symptoms for a time but do not stop the downward progression of disease.
Additional work needs to be done to evaluate the accuracy of the technique. And doing PET scans with brain dyes is an expensive procedure that cannot be routinely performed in a doctor’s office. Still, the findings add another piece of the puzzle to diagnosing Alzheimer’s disease at earlier stages, potentially allowing patients, family members and doctors to plan for the future more effectively.

By ALZinfo.org, The Alzheimer’s Information Site. Reviewed by William J. Netzer, Ph.D., Fisher Center for Alzheimer’s Research Foundation at The Rockefeller University.
Christopher M. Clark, MD; Julie A. Schneider, MD; Barry J. Bedell, MD, PhD; et al: “Use of Florbetapir-PET for Imaging Beta-Amyloid Pathology.” Journal of the American Medical Association, Vol. 305 (No. 3), January 19, 2011, pages 275-283.
Brain Scans Lead to Earlier Alzheimer’s Diagnosis | Fisher Center for Alzheimer's Research Foundation

Saturday, May 14, 2011

Breathing 4 Life's Memory: Breathing 4 Life's Memory: Walk With Us To End Alzheimer's Oct9 LA,CA

Breathing 4 Life's Memory: Breathing 4 Life's Memory: Walk With Us To End Alzheimer's Oct9 LA,CA: "Join the Alzheimer's Association Walk to End Alzheimer's™ and unite in a movement to reclaim the future for millions. Together, we can end Alzheimer's disease the nation's sixth-leading cause of death"

Breathing 4 Life's Memory: Walk With Us To End Alzheimer's Oct9 LA,CA


Join the Alzheimer's Association Walk to End Alzheimer's™ and unite in a movement to reclaim the future for millions. Together, we can end Alzheimer's disease the nation's sixth-leading cause of death.

Breathing 4 Life's Memory: Walk To End Alzheimer's Promotional Video

Breathing 4 Life's Memory: Walk To End Alzheimer's Promotional Video: "JOIN OUR TEAM & TAKE ACTION WITH US ON OCT 9th LOS ANGELES CA !!!! http://www.facebook.com/MovingLivingMemories"

Walk To End Alzheimer's Promotional Video




JOIN OUR TEAM & TAKE ACTION WITH US ON OCT 9th LOS ANGELES CA !!!!
http://www.facebook.com/MovingLivingMemories

Thursday, May 12, 2011

Breathing 4 Life's Memory: Image via Wikipedia var _gaq = _gaq || []; _gaq....

Breathing 4 Life's Memory:: "Recognizing the Contributions of those with Alzheimer’s May is Older American ’s Month and a good time to t..."

PET scan of a human brain with Alzheimer's diseaseImage via Wikipedia
Recognizing the Contributions
 of those with Alzheimer’s

 May is Older American’s Month and a good time to think about all those with Alzheimer’s disease who have perhaps become nothing more than the sum of their disease to those around them. 
As a caretaker for a person with Alzheimer’s it is sometimes easy to forget who the person was prior to the disease which is destroying their mind and memories. In the words of Dorothy Seman, a nurse at the Alzheimer’s Family Care Center in Chicago, “People with dementia are more than plaques and tangles.” 
It is especially important to speak with those in the early stages of Alzheimer’s in order to gain valuable insights into their minds and their lives, allowing them to retain their dignity as the disease progresses. 
 Older Americans Month 2011 Older Americans Month is a wonderful occasion to show our appreciation for all seniors and remember how much enrichment they have brought to our lives and our communities. 
The theme for this year’s Older Americans Month is: Older Americans: Connecting the Community, and this theme is particularly applicable to those who suffer from Alzheimer’s disease. After all, these people were once a vital part of their community. They worked in jobs, had families, made contributions to our world, and it is extremely important for us to look at those who suffer from Alzheimer’s and fully recognize those specific contributions.

 Labeling Those with Alzheimer’s Unfortunately, we tend to label people who have Alzheimer’s or other diseases, and stop seeing them as a person. Each person who has Alzheimer’s disease will both react and deal with the disease differently; some will show improvement while taking certain drugs, others will not. 
While it is a common belief that those with Alzheimer’s do not clearly understand their disease, it’s much more likely they are simply in denial due to the many unpleasant stigmas which surround Alzheimer’s and dementia.
 A certain level of denial may be a necessity in order for the person with Alzheimer’s to deal with such a disease; however this in no way means they don’t understand what is happening to them. Most all people with Alzheimer’s disease experience a fear of the future, and of losing their sense of self while still living and breathing. 
 Older Americans Month is the perfect time to recall the person the disease may be hiding, and celebrate their life.

 Share and Enjoy: This entry was posted in Uncategorized and tagged alzheimer, alzheimer's disease, alzheimers, dementia, memories, older americans, older americans month, seniors. Bookmark the permalink.
Enhanced by Zemanta

Tuesday, May 10, 2011

Packing On The Pounds In Middle Age Linked To Dementia


Packing On The Pounds In Middle Age Linked To Dementia
May 5, 2011
According to a new study, being overweight or obese during middle age may increase the risk of certain dementias. The research is published in the May 3, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.

"Currently, 1.6 billion adults are overweight or obese worldwide and over 50 percent of adults in the United States and Europe fit into this category," said study author Weili Xu, MD, PhD, with the Karolinska Institutet in Stockholm, Sweden. "Our results contribute to the growing evidence that controlling body weight or losing weight in middle age could reduce your risk of dementia."
Researchers studied information from the Swedish Twin Registry on 8,534 twins age 65 or older. Of those, 350 were diagnosed with dementia and 114 had possible dementia. Information on participant's height and weight had been taken 30 years earlier.

Participants were grouped according to their body mass index (BMI), a measure of total body fat: underweight, normal weight, overweight and obese. Being overweight was defined as having a body mass index between 25 and 30 and obesity was defined as a body mass index of higher than 30. In the study, 2,541 twins, or nearly 30 percent, were either overweight or obese during middle age.

The study found that people who were overweight or obese at midlife had an 80 percent higher risk of developing dementia, Alzheimer's disease or vascular dementia in late life compared to people with normal BMI. The results remained the same after considering other factors, such as education, diabetes and vascular disease. A total of 26 percent of those with no dementia had been overweight in midlife, compared to 36 percent of those with questionable dementia and 39 percent of those with diagnosed dementia. Three percent of those with no dementia had been obese in midlife, compared to five percent of those with questionable dementia and seven percent of those with diagnosed dementia.
The researchers also analyzed the data in twin pairs where one twin had dementia and one twin did not and found that there was no longer a significant relationship between overweight and obesity and dementia in midlife. "This suggests that early life environmental factors and genetic factors may contribute to the link between midlife overweight and dementia," Xu said.
Adapted from the American Academy of Neurology

View all news updates for Alzheimer's disease
Disclaimer: The information provided in this section is a public service of the American Health Assistance Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. The American Health Assistance Foundation does not endorse any medical product or therapy.Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.Enhanced by Zemanta

Friday, May 6, 2011

Seth Rogen: Alzheimer's is 'brutal' - CNN.com

Seth Rogen: Alzheimer's is 'brutal' - CNN.com



Please Dont Cry - jasmineelisa87@gmail.com - Gmail

Please Dont Cry - jasmineelisa87@gmail.com - Gmail
Norm mcnamara to Anne.Rollings



Please don’t

Cry

When it’s time to say goodbye,

Please don’t worry, please don’t cry,

I have lived such a wonderful life,

Had my children, wed a beautiful wife,

I have lived life to the full,

It was never boring, never dull,

Every day was well spent,

With my family, heaven sent,

So no regrets, and no tears,

Hush your sobs, quell your fears,

Remember me with a grin,

And your new life please begin,

So when it’s time to say goodbye,

Please don’t worry, please don’t cry,

I am always here next to you,

The sun will shine through skies so blue

Best wishes, Norrms and family xxxxxxxxxxxxx




Sunday, May 1, 2011

We are looking for people with probable Alzheimer’s disease, and their caregivers, to participate



Alzheimer's disease has them needing you more than ever. We need you, too.
Alzheimer’s disease (AD) affects an estimated 18 million people and their families all over the world.  While there is still no cure, participating in clinical trials can help future generations better understand and develop treatments for this debilitating condition.
Researchers at 25 clinics in the US are conducting a research study to test the safety and effectiveness of an injectable investigational treatment to determine if it can slow the rate of Alzheimer’s disease progression. We are looking for people with probable Alzheimer’s disease, and their caregivers, to participate.

Learn more about this AD study

You or someone in your care may be eligible to participate in this study.
Click the button above to answer a few questions to find out if you or someone in your care is eligible to participate in this AD study.

Saturday, April 30, 2011

Fisher Center Scientists Show That Anti-Inflammatory Drugs Reduce Effectiveness of SSRI Antidepressants | Fisher Center for Alzheimer's Research Foundation


Fisher Center Scientists Show That Anti-Inflammatory Drugs Reduce Effectiveness of SSRI Antidepressants | Fisher Center for Alzheimer's Research Foundation  



Fisher Center Scientists Show That Anti-Inflammatory Drugs Reduce Effectiveness of SSRI Antidepressants


Scientists at the Fisher Center for Alzheimer’s Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, aspirin and naproxen, reduce the effectiveness of the most widely used class of antidepressant medications, the selective serotonin reuptake inhibitors, or SSRIs, taken for depression, obsessive-compulsive disorder and anxiety disorders. This surprising discovery, published online this week in the Proceedings of the National Academy of Sciences, may explain why so many depressed patients taking SSRIs do not respond to antidepressant treatment and suggests that this lack of effectiveness may be preventable. The study may be especially significant in the case of Alzheimer’s disease. Such patients commonly suffer from depression and unless this can be treated successfully, the course of the illness is likely to be more severe. Depression in the elderly is also a risk factor for developing Alzheimer’s disease and researchers have suggested that treating depression in the elderly might reduce the risk of developing the disease.
In the recent study, investigators treated animal models with antidepressants in the presence or absence of anti-inflammatory drugs. They then examined how the models behaved in tasks that are sensitive to antidepressant treatment. The behavioral responses to antidepressants were inhibited by anti-inflammatory/analgesic treatments. They then confirmed these effects in a human population. Depressed individuals who reported anti-inflammatory drug use were much less likely to have their symptoms relieved by an antidepressant than depressed patients who reported no anti-inflammatory drug use. The effect was rather dramatic since, in the absence of any anti-inflammatory or analgesic use, 54% of patients responded to the antidepressant, whereas, success rates dropped to approximately 40% for those who reported using anti-inflammatory agents.
“The mechanism underlying these effects is not yet clear. Nevertheless, our results may have profound implications for patients, given the very high treatment resistance rates for depressed individuals taking SSRIs,” noted Dr. Warner-Schmidt. Dr. Greengard added, “Many elderly individuals suffering from Alzheimer’s disease also have arthritic or related diseases and as a consequence are taking both antidepressant and anti-inflammatory medications. Our results suggest that physicians should carefully balance the advantages and disadvantages of continuing anti-inflammatory therapy in patients being treated with antidepressant medications.”
This is the third significant finding in nine months by Fisher Scientist in Dr. Greengard’s lab. Previously, Fisher Center researchers headed by Nobel laureate Dr. Paul Greengard in the Fisher laboratory at The Rockefeller University found two new ways to control beta-amyloid. In September of 2010 published in Nature, they discovered a previously unknown function for a protein in the brain that stimulates the production of beta-amyloid which is known to contribute to the cause of Alzheimer’s. Controlling this protein, called gSAP, is a key and also has the advantage of not interfering with other life functions which caused the failure of many earlier drug trials. In another finding published in the FASEB Journal in March 2011, they also succeeded in accelerating the breakdown of accumulated beta-amyloid. They discovered that a process called autophagocytosis reduces the buildup of beta-amyloid in isolated cells and might be utilized to eliminate the buildup of beta-amyloid in the brains of Alzheimer’s patients. They discovered that a compound called SMER28 lowers the level of beta-amyloid found in nerve cells. According to Dr. Greengard, “the combination of inhibition of formation and acceleration of breakdown of beta-amyloid represents a new and powerful strategy for treating Alzheimer’s disease.”
“This is the third major finding by the Fisher Center scientists at the Greengard lab in only nine months,” says Kent L. Karosen, President of the Fisher Center for Alzheimer’s Research Foundation. “It’s quite amazing that their novel techniques are proving to be so prolific. This latest finding shows their success in not only one day ending Alzheimer’s, but in also having even broader implications for society.”
The Fisher Center for Alzheimer’s Research Foundation is a leading source of funding for Alzheimer’s research and education. They serve Alzheimer’s patients and their families by seeking to understand the causes of, discover a cure for, and improve the lives of people with Alzheimer’s disease. Nobel laureate Dr. Paul Greengard directs the Foundation’s team of internationally renowned scientists. Of the money raised by the Foundation, only 9 cents out of every dollar is used for overhead and administrative purposes. For more information about the Fisher Center for Alzheimer’s Research Foundation,click here.

Thursday, April 28, 2011

California Budget Cuts at Odds With State’s New Alzheimer’s Plan

Alzheimer's patient Felipe Garcia, at right in above photo, is shown with his sons Marco, left, and Oscar, center.

Part 1 of 2. Read Part 2 here. 

MOUNTAIN VIEW, Calif.—Felipe Garcia, 79, looks up with a ready smile as his two-year-old granddaughter, Marina, orbits his shuffling legs—her mother Elena keeping a sharp eye on the toddler to avoid any mishaps around the family’s modest home in Silicon Valley. Elena says Marina doesn’t quite understand yet that her abuelo (grandpa) has Alzheimer’s disease and can’t concentrate on her for long periods of time. 

Felipe, who migrated from Mexico in his youth, is among 5.5 million Americans diagnosed with Alzheimer’s. Of those cases, 588,000 are in California, a number that is expected to double by 2030. The number of Latinos and Asians living with the disease will triple during the same time period, according to a new state plan jointly released by the Alzheimer’s Association, California’s Health and Human Services Agency and the Alzheimer’s Disease and Related Disorders Advisory Committee.

Yet the plan’s chief recommendation—to meet the projected shortage of caregiving resources by expanding home and community services, thus keeping people out of costly nursing homes—may be in jeopardy. Last Thursday, Gov. Jerry Brown signed into law the latest round of budget cuts to services the Garcias rely on to manage care for both Felipe and his wife Manuela, 65, who has diabetes, heart disease and other ailments. 

Three Garcia Households Under One Roof

California’s new Alzheimer’s plan shows that families like the Garcias provide three-quarters of the intensive care for those afflicted with the illness. Only 6 percent of Alzheimer’s patients are in nursing homes, and many families go to great lengths to keep their loved ones out of institutions. 

Three households of Garcias—those of Felipe and Manuela, their son Marco and his wife Elena, and their son Oscar—took the unusual step of pooling their resources to purchase the home the elder Garcias had rented for decades. They rebuilt it with six bedrooms and a basement, enough space to house the entire family. 

The two sons and daughter-in-law divide daily labors of love, such as preparing meals, managing multiple medications and getting Felipe and Manuela to doctor’s appointments. 

“It gets a little hectic,” says Marco, a Mountain View police officer, who works night shifts. “You’re trying to eat dinner, the kids [are] running around—everyone’s on a different schedule.”

Then, he said, there are those Alzheimer’s moments. Sometimes Felipe “wakes up stubborn,” Marco says. For instance, he may insist on going up to the attic, a potentially dangerous climb for the frail older man. “So I spend 10 minutes going back and forth about why he shouldn’t go to the attic.”

A key conclusion of the Alzheimer’s plan for California—one of 26 states to develop a plan so far—is that dedicated families such as the Garcias still need help to manage the labor-intensive challenges of caregiving. 

The plan cites one indication of how arduous dementia care is: The cost of nursing home care for Alzheimer’s patients on MediCal (California’s Medicaid program) is 2.5 times greater than that of seniors without the disease.

California Cuts Care, While Other States Expand It

Faced with a fiscal crisis, California has been cutting exactly the kinds of programs the state plan prescribes. Some experts say the cuts actually will drive up costs and unnecessarily force many elders into expensive nursing homes or hospitals. 

The new Alzheimer’s plan asserts, “Unless the state takes steps to provide better support in the home and community for those who are affected by this condition, volume [of Alzheimer’s cases] alone will cripple public resources.” 

The report emphasizes that programs such as California’s In-Home Supportive Services (IHSS) and Adult Day Health Care (ADHC) help keep elders like Felipe Garcia in the family fold. 

However, California lawmakers have cut funding for the state’s 310 ADHCs by more than half, to $85 million. That represents a compromise; in his original budget, Brown called for eliminating the program entirely. The new law also would bring federal matching funds, but only by restructuring the program with federal approval, a process that could take months.

“Nothing good can come from 50-plus percent reductions,” says Marty Lynch, executive director of the nonprofit LifeLong Medical Care in Berkeley. “A lot fewer patients and probably fewer services.”

Lydia Missaelides, who heads the California Association of Adult Day Services, adds that even if the transition to the new funding design is seamless—avoiding family disruption and possible center closures for lack of funds—the strict new eligibility rules and huge cuts will leave many families scrambling. 

“These are people who the state already qualified as at-risk for a nursing home,” she explains. But because ADHC patients now must be at high medical risk of being institutionalized, a borderline patient—for example, someone at an earlier stage of the illness—would lose the preventive nursing care provided by the center and end up seeking emergency services.

Among numerous other budget cuts are $1.7 billion slashed from MediCal and $486 million from IHSS. Fortunately, Missaelides says, the reductions in home assistance—which already suffered deep cuts last year—will be partly offset by funds from the federal Community First Choice program, part of the health care reform law. But more cuts are on the way, including $2.5 million expected to be cut from the case management program for seniors.

This year’s program cuts would curtail assistance to 400,000 vulnerable Californians, who will be forced to turn to more costly emergency care.

“By limiting the availability of these services to only people who are already at an acute level of need, we erase the tremendous savings potential of prevention,” says Wendy Peterson, director of the Senior Services Coalition of Alameda County.

In fact, 32 states dealing with budget crises have actually chosen to expand home- and community-based care programs to save money in the long term, according to a 2010 survey by the Kaiser Family Foundation.

But for H.D. Palmer of the California Department of Finance, “These choices are difficult but necessary.” He insists that the state’s $26.6 billion deficit leaves lawmakers little alternative but to reduce funds for many popular programs. 

Meanwhile, according to the new Alzheimer’s plan, by 2030, nearly 1.2 million elders in the Golden State will suffer from the incurable disease—with state costs more than doubling from today’s expenditures to $31.3 billion a year.

Alzheimer’s also costs California businesses up to $1.4 billion a year in lost productivity, according to the report, as caregivers miss work, cut their hours or switch jobs.

The report, “California’s State Plan For Alzheimer’s Disease: An Action Plan for 2011-2021,” was ordered by the Legislature to address the looming public health crisis as people live longer with chronic illnesses.

It was the culmination of a two-year effort involving state agencies, nonprofit organizations, and more than 2,500 people ranging from experts to family caregivers and Alzheimer’s patients themselves. Also supporting the project were the California Endowment and the SCAN, Gilbert and Archstone foundations.

Research included an online survey of 1,320 caregivers in English, Spanish, Korean, Vietnamese and Chinese.

Investment in the Middle Class

Oscar Garcia, Felipe and Manuela’s son, is the president and CEO of the Mountain View Chamber of Commerce and a member of the Alzheimer’s Association board in Northern California. He says that working professionals, as well as the poor, need the state’s family caregiving assistance. 

“When you look at the medical cost for a facility that specializes in Alzheimer’s, it is prohibitively expensive,” he says.

Like millions of Americans, Oscar found himself “very, very surprised” to learn that Medicare does not cover long-term care services and that affordable private long-term care insurance was not available for his parents. 

“IHSS and adult day care essentially fill in the gap for middle-income people,” Oscar says. “What those programs do is bridge the gap and allow middle America to continue to work and be productive and contribute their taxes, which go back into the economy to be able to fund and provide more. Middle America I view as the engine that pulls this economy.”

Sitting in the Garcias’ living room surrounded by framed family photographs, Oscar chuckles when asked about the collection of carved white elephants on a shelf. 

“Dad loves them,” Oscar says. Replying to the next question, he laughs, “No, he’s a Democrat. I’m a Republican, but he’s a Democrat.”
This is the first of two articles.
Enhanced by Zemanta

Breathing 4 Life's Memory: Lost in translation: As elderly Latino population ...

Breathing 4 Life's Memory: Lost in translation: As elderly Latino population ...: "Lost in translation : As elderly Latino population booms, a rush to boost knowledge of Alzheimer's Discussion By SUZETTE LABOY - Associated ..."

Lost in translation: As elderly Latino population booms, a rush to boost knowledge of Alzheimer's


Lost in translation: As elderly Latino population booms, a rush to boost knowledge of Alzheimer's
DiscussionBy SUZETTE LABOY - Associated Press
Posted: Wednesday, March 30, 2011 12:01 am |


Ida and William Gonzalez bring in the laundry at their home in Davie, Fla. When Ida was diagnosed with Alzheimer's disease, her husband knew little about the scourge that was gradually robbing his wife of a lifetime of memories. (AP Photo/Lynne Sladky)
DAVIE, Fla. ---- William Gonzalez's world collapsed when his wife of more than 50 years was diagnosed with Alzheimer's disease four years ago. The 78-year-old Cuban immigrant knew little about the scourge that was gradually robbing his wife of a lifetime of memories.
Today, the Air Force veteran struggles to run his home in Davie, Fla., while serving as sole caretaker for his 74-year-old wife, Ida.
In increasing numbers, Latinos are facing the wrenching prospect of helping a loved one battle the most common form of dementia. The population of elderly Latinos is projected to grow the fastest of all U.S. racial and ethnic groups in coming years, from just under 3 million in 2008 to 17.5 million in 2050, according to the Federal Interagency Forum on Aging-Related Statistics.
That has Alzheimer's groups pushing to raise awareness among Latinos who are living longer, into the decades when the risk of Alzheimer's rises dramatically.
The Alzheimer's Association "Know the 10 Signs" workshop in Spanish is being offered at the more than 70 chapters nationwide.
A support group started by The Latino Alzheimer's & Memory Disorders now meets twice monthly in different Chicago locations. In Milwaukee, the Latino Geriatric Center provides screenings for memory loss and support groups.
Complications from Alzheimer's is the sixth leading cause of death for non-Hispanics and 12th leading cause of death among Hispanics, according to data from the Centers for Disease Control and Prevention in Atlanta. Yet the nation's largest, private nonprofit funder of Alzheimer's research ---- the Alzheimer's Association ---- warns that the number of older Latinos with Alzheimer's and related dementias could rise more than sixfold from fewer than 200,000 cases today to as many as 1.3 million by 2050, based on rates of population growth.
"We want to make sure we increase concern and awareness as much as we can and extend our services and support," said Janis Robinson, an association official.
Experts say some Latinos are reluctant to make medical appointments, which means long delays from when symptoms are first noticed until a neurologist is seen. When they do decide to see a doctor, it can be a challenge finding one fluent in Spanish.
Add to that the stigma often attached to mental illness ---- the Spanish word for dementia is "demencia," which roughly translates as "crazy" ---- and Latinos face daunting barriers to frank discussion about such diseases.
"I look at it as what cancer was 10 or 15 years ago. People never talked about it or the c-word," said Serge Morales, 72, a retiree of Mexican descent in Agoura Hills.
He and his wife, Susan, knew little about dementia until she was diagnosed at 58 with early-onset Alzheimer's. Susan Morales, who has a nursing degree, has made Los Angeles-area speaking appearances to raise awareness about a disease normally associated with the elderly.
"She's very young-looking, and we just want to make sure that people understand that it can happen to you at a young age," Sergio Morales said.
Dr. Elizabeth Crocco, an Alzheimer's expert at the University of Miami School of Medicine, recalls one patient who was living in Puerto Rico and whose siblings hid her disease from her grown children in Miami. When her son discovered his mother had problems driving and paying the bills, he moved her to Florida for treatment.
"They got angry at him for taking her away," Crocco said of the older siblings. "It was the professional younger son against the older generation."
Arturo Flores, 38, a technician, is the youngest of four children and lives with his parents in Culver City. His Mexican father, Ricardo, has Alzheimer's. Flores, who is single, said caring for his father has affected his life more than he expected, but he feels a duty to the father who raised him.
"I can't really talk to him about certain things in my life I wish I could," said Flores, who has cried many times since his father's diagnosis. "He can't get his ideas out anymore. I see him more as my son now."
In South Florida, Gonzalez's wife was diagnosed four years ago after someone noticed she was speaking English to a Spanish-speaking friend. Now he's struggling with the toll of coping with her disease, vexed when she barely noticed the Christmas ornaments he put up at their home for the holidays.
"That's kind of frustrating, but it's not her. It's the disease," said Gonzalez, who sought relief at weekly support meetings with others who care for Alzheimer's patients.
Fighting back tears, he recalled how he asked his three grown children for their support shouldering the load his wife's disease has placed on him: "You better keep me alive, or try to. Because if I'm OK and here, I can take care of her," he said.
___
Online:
Alzheimer's Association: http://www.alz.org/documents_custom/report_alzfactsfigures2010.pdf
http://www.alz.org/alzheimers_disease_10_signs_of_alzheimers.asp
Copyright 2011 North County Times - The Californian. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Posted in Health-med-fit on Wednesday, March 30, 2011 12:01 am | Tags: Health, News,







Enhanced by Zemanta

Monday, April 25, 2011

Breathing 4 Life's Memory



ACT To END AD !